Literature DB >> 1936077

Investigations on the in vitro metabolism of five synthetic 19-norprogestins using hepatocyte suspensions isolated from five laboratory animal species.

L Qi-Gui1, Z Ming-Da, M Hümpel.   

Abstract

Five synthetic progestins of the 19-nortestosterone type (norethisterone, NET; levonorgestrel, LN; gestodene, GEST; NET-3-oxime, NETO; norgestimate, NGM) were investigated in the in vitro hepatocyte model. Radiolabelled progestins were added to hepatocyte suspensions (3 x 10(6) cells/ml) freshly prepared from female rat, guinea pig, rabbit, dog (beagle) and cynomolgus monkey. Drug level decreases (NET, LN, GEST) and prodrug conversions (NETO, NGM) were followed by radiochromatography (HPLC) for 60 min. In the case of NET and NETO the conversion into ethinyl estradiol (EE2) was quantified by RIA after HPLC separation. Half-lives of drug level decreases (t1/2), areas under the curves (AUC) and metabolic clearance rates (MCR) were estimated for all progestins. For NETO and NGM the percentages of conversion into NET and LN were calculated, respectively, and levels of EE2 determined in the case of NET and NETO. Rat hepatocytes showed an extremely high metabolic activity towards NET, LN and GEST resulting in t1/2 values of below 2 min. Respective values for rabbit hepatocytes ranged from 5-8 min, whereas half-lives calculated for liver cells from guinea pig, dog and monkey were generally above 30 min. A drastic increase in t1/2 was found for NETO (as compared to NET) in hepatocytes from rat, rabbit and monkey but not from guinea pig. Dog hepatocytes degraded NETO about 3 times more rapidly than NET. NGM was degraded much faster than LN in hepatocytes from all species except the rat. Liver cells from guinea pig and dog seem to be able to metabolize the 3-oxime group much more rapidly than hepatocytes from the other animal species. The lowest degree of prodrug conversion of 4% was observed for NGM and dog hepatocytes. Elevated EE2 levels were found in all experiments with NET and NETO. Results of NET, LN and GEST were compared with published in vivo experiments. No correlations were found for t1/2, MCR, and AUC.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1936077     DOI: 10.1007/BF03189944

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  17 in total

Review 1.  Suitability of animal models for predictive toxicology: theoretical and practical considerations.

Authors:  E J Calabrese
Journal:  Drug Metab Rev       Date:  1984       Impact factor: 4.518

2.  Isolated perfused rat liver technique.

Authors:  D K Meijer; K Keulemans; G J Mulder
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

3.  Isolation and use of liver cells.

Authors:  P Moldéus; J Högberg; S Orrenius
Journal:  Methods Enzymol       Date:  1978       Impact factor: 1.600

4.  Isolation and culture of adult hepatocytes from liver biopsies.

Authors:  J A Reese; J L Byard
Journal:  In Vitro       Date:  1981-11

5.  Statistical estimation of the minimal detectable concentration ("sensitivity") for radioligand assays.

Authors:  D Rodbard
Journal:  Anal Biochem       Date:  1978-10-01       Impact factor: 3.365

6.  Norethisterone-4 beta,5-oxide and laevonorgestrel-4 beta,5-oxide: formation in rat liver microsomal incubations and interference with microsomal epoxide hydrolase and cytoplasmic glutathione S-transferase.

Authors:  H Peter; R Jung; H M Bolt; F Oesch
Journal:  J Steroid Biochem       Date:  1981-01       Impact factor: 4.292

7.  The confirmation of norethindrone aromatization in primary human hepatocytes by the Vitafiber-II cell culture system.

Authors:  T Yamamoto; J Kitawaki; K Shiroshita; M Urabe; J Sasaki; M Fukuoka; K Naitoh; H Honjo; H Okada
Journal:  Nihon Sanka Fujinka Gakkai Zasshi       Date:  1988-01

8.  Correlation of drug conjugative metabolism rates between in vivo and in vitro: glucuronidation and sulfation of p-nitrophenol as a model compound in rat.

Authors:  T Mizuma; M Machida; M Hayashi; S Awazu
Journal:  J Pharmacobiodyn       Date:  1982-10

9.  Studies on the biotransformation of lonazolac, bromerguride, lisuride and terguride in laboratory animals and their hepatocytes.

Authors:  M Hümpel; D Sostarek; H Gieschen; C Labitzky
Journal:  Xenobiotica       Date:  1989-04       Impact factor: 1.908

10.  Correlation between in vitro and in vivo drug metabolism rate: oxidation of ethoxybenzamide in rat.

Authors:  J H Lin; M Hayashi; S Awazu; M Hanano
Journal:  J Pharmacokinet Biopharm       Date:  1978-08
View more
  1 in total

1.  A phase 1, open-label study to evaluate the drug interaction between islatravir (MK-8591) and the oral contraceptive levonorgestrel/ethinyl estradiol in healthy adult females.

Authors:  Wendy Ankrom; Deanne Jackson Rudd; Saijuan Zhang; Kerry L Fillgrove; Kezia N Gravesande; Randolph P Matthews; Darin Brimhall; S Aubrey Stoch; Marian N Iwamoto
Journal:  J Int AIDS Soc       Date:  2021-12       Impact factor: 5.396

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.